Dorothy G. Walker
About
In The Last Decade
Dorothy G. Walker
16 papers receiving 255 citations
Peers
Comparison fields: 5 of 70
- Psychiatry and Mental health 95
- Oncology 87
- Molecular Biology 84
- Dermatology 35
- Cancer Research 34
Countries citing papers authored by Dorothy G. Walker
This map shows the geographic impact of Dorothy G. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothy G. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothy G. Walker more than expected).
Fields of papers citing papers by Dorothy G. Walker
This network shows the impact of papers produced by Dorothy G. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothy G. Walker. The network helps show where Dorothy G. Walker may publish in the future.
Co-authorship network of co-authors of Dorothy G. Walker
This figure shows the co-authorship network connecting the top 25 collaborators of Dorothy G. Walker. A scholar is included among the top collaborators of Dorothy G. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothy G. Walker. Dorothy G. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Efficacy and Safety in Key Patient Subgroups of Nivolumab (Nivo) Alone Or Combined with Ipilimumab (Ipi) Versus Ipi Alone in Treatment-Naive Patients with Advanced Melanoma | 2 |
| 2 | 1 | |
| 3 | Population of HLA-DR+ Immature Cells Accumulate in the Blood Dendritic Cell Compartment of Patients with Different Types of Cancer | 0 |
| 4 | 107 | |
| 5 | 11 | |
| 6 | 11 | |
| 7 | Cytologic studies on human malanoma cells in tissue culture after exposure to five chemotherapeutic agents. | 0 |
| 8 | Preliminary clinical and laboratory investigation of a chemotherapeutic agent in the treatment of brain tumors. | 4 |
| 9 | 5 | |
| 10 | 27 | |
| 11 | 3 | |
| 12 | Cytological alterations in primary explant cultures of human neoplasms exposed to vincaleukoblastine. | 5 |
| 13 | In vitro selection of chemotherapeutic agents for perfusion therapy of human cancer. | 8 |
| 14 | 39 | |
| 15 | 13 | |
| 16 | Comparative chemotherapy studies on primary short-term cultures of human normal, benign, and malignant tumor tissues--a five-year study. | 30 |
| 17 | Studies on human melanoma cells in tissue culture. I. Growth characteristics and cytology. | 21 |
| 18 | 21 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.